Search hospitals > Montana > Kalispell

Kalispell Regional Medical Center

Claim this profile
Kalispell, Montana 59901
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Relapse
510 reported clinical trials
3 medical researchers
Photo of Kalispell Regional Medical Center in KalispellPhoto of Kalispell Regional Medical Center in Kalispell

Summary

Kalispell Regional Medical Center is a medical facility located in Kalispell, Montana. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Relapse and other specialties. Kalispell Regional Medical Center is involved with conducting 510 clinical trials across 549 conditions. There are 3 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, and Alison Schneider.

Area of expertise

1Skin Cancer
Global Leader
Kalispell Regional Medical Center has run 149 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Kalispell Regional Medical Center has run 92 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Kalispell Regional Medical Center

Breast Cancer
Skin Cancer
Lung Cancer
Bladder Cancer
Prostate Cancer
Breast cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Pancreatic Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kalispell Regional Medical Center?
Kalispell Regional Medical Center is a medical facility located in Kalispell, Montana. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Relapse and other specialties. Kalispell Regional Medical Center is involved with conducting 510 clinical trials across 549 conditions. There are 3 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, and Alison Schneider.
Where is Kalispell Regional Medical Center located?
**Directions to Kalispell Regional Medical Center:** - If heading north on U.S. Highway 93, turn right onto Sunnyview Lane. - If traveling south on U.S. Highway 93, turn left onto Sunnyview Lane.
Who should I call to ask about financial aid or insurance network?
Kalispell Regional Medical Center, part of Logan Health, provides financial assistance for patients struggling to pay their medical bills. Patients can apply by filling out the Financial Assistance Application Form on the hospital's website. This program is open to all patients, regardless of insurance status. For more information, contact the financial assistance department at (406) 752-5125.
What insurance does Kalispell Regional Medical Center accept?
The Kalispell Regional Medical Center, also known as Logan Health, accepts a variety of insurance plans. This includes Blue Cross and Blue Shield of Montana (BCBSMT), which offers individual, family, Medicare, and Medicaid plans with COVID-19 coverage. Additionally, the hospital works with plans available through the Montana Health Insurance Marketplace, providing a comprehensive resource for residents to explore insurance options, understand subsidies, and learn about enrollment periods.
What awards or recognition has Kalispell Regional Medical Center received?
**Logan Health Medical Center** - Recognized for its commitment to research and patient care. - Actively participates in clinical trials to advance disease prevention, treatment, and detection. - Awarded for outstanding performance as a rural community hospital, emphasizing its dedication to high-quality healthcare services in a non-urban setting.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security